The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Gene Therapy Market Expected To Change Between 2026 And 2030?
The gene therapy market has seen considerable expansion in recent years. This market is set to expand from $16.36 billion in 2025 to $21.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 31.2%. The historical development of this market can be attributed to several factors including the rising occurrence of genetic disorders, enhancements in viral vector technology, increased research and development investments in gene therapy, favorable government policies, and greater public awareness of rare diseases.
The gene therapy market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $35.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This expansion during the projection period stems from several factors, including the increasing scope of personalized medicine, the advent of crispr and other gene editing treatments, a rise in both private and public investment, the incorporation of AI into gene therapy investigations, and the proliferation of international collaborative clinical trials. Key trends expected over this period encompass the advancement of personalized gene therapies, the widespread adoption of crispr and gene editing technologies, the broadening of regulatory and ethical guidelines, breakthroughs in advanced viral and non-viral vector systems, and ongoing collaborative research and clinical studies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp
What Underlying Factors Are Accelerating The Growth Of The Gene Therapy Market?
Future expansion of the gene therapy market is anticipated to be driven by increasing investment within the healthcare industry. Investment in the healthcare industry involves channeling capital into businesses offering medical services, producing medical devices or pharmaceuticals, supplying medical insurance, or otherwise participating in the healthcare sector. Such investments are crucial for the gene therapy industry, given that numerous pharmaceutical firms are allocating resources to strengthen their patent holdings and establish profitable collaborations. Furthermore, calculated investments facilitate the creation of novel and sophisticated gene therapy products. For example, data from April 2025, supplied by the American Medical Association, a US-based Professional organizations, indicates that in 2023, U.S. health spending surged by 7.5% to $4.9 trillion, equivalent to $14,570 per capita, exceeding the 4.6% rise observed in 2022. Consequently, the increased capital flowing into the healthcare industry is fueling the expansion of the gene therapy market.
How Is The Gene Therapy Market Structured Across Different Segments?
The gene therapy market covered in this report is segmented –
1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
2) By Vector: Viral Vector, Non-Viral Vector
3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users
Subsegments:
1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations
2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques
Which Trends Are Shaping The Future Of The Gene Therapy Market?
Leading companies engaged in the gene therapy market are prioritizing the development of advanced products, including adeno-associated virus (AAV) vectors, to elevate the precision and overall effectiveness of gene delivery when treating various genetic disorders. An adeno-associated virus (AAV) vector is a widely utilized instrument in gene therapy for transferring genetic material into cells. As an illustration, in April 2024, Pfizer Inc., a US-based global biopharmaceutical company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health, for BEQVEZ (fidanacogene elaparvovec-dzkt). BEQVEZ (fidanacogene elaparvovec-dzkt) is a gene therapy designed for managing adults experiencing moderate to severe hemophilia B, which is a genetic bleeding disorder. This particular condition is identified by a deficiency in clotting factor IX (FIX), potentially leading to excessive bleeding. The therapy employs an adeno-associated virus (AAV) vector to deliver a functional duplicate of the FIX gene directly into liver cells, thereby facilitating the body’s natural production of this essential clotting factor.
Which Major Players Dominate The Gene Therapy Market?
Major companies operating in the gene therapy market are UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, BrainStorm Cell Therapeutics, Pluristem, Sanofi
Read the full gene therapy market report here:
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Which Region Is Projected To Dominate The Gene Therapy Market During The Forecast Period?
North America was the largest region in the gene therapy market in 2025. The regions covered in the gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Gene Therapy Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp
Browse Through More Reports Similar to the Global Gene Therapy Market 2026, By The Business Research Company
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Nucleic Acid Based Gene Therapy Market Report 2026
Gene Editing Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model